FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mary Ellyn Witt

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Tanguy Seiwert; Kerstin M Stenson; V Villaflor; E A Blair; E E W Cohen; T Darga; Daniel J Haraf; M W Lingen; Joseph K Salama; R R Weichselbaum; Mary Ellyn Witt; E E Vokes
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
D W Golden; E Blair; E E W Cohen; T Nwizu; S Rudra; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Daniel J Haraf
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Kent W Mouw; Elizabeth A Blair; Ezra E W Cohen; Daniel J Haraf; Marcy A List; Abhishek A Solanki; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Joseph K Salama
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mary Ellyn Witt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tanguy Seiwert; Kerstin M Stenson; V Villaflor; E A Blair; E E W Cohen; T Darga; Daniel J Haraf; M W Lingen; Joseph K Salama; R R Weichselbaum; Mary Ellyn Witt; E E Vokes
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(3):769-76.
2013: D W Golden; E Blair; E E W Cohen; T Nwizu; S Rudra; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Daniel J Haraf
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Oral oncology 2013;49(3):277-82.
2012: Kent W Mouw; Elizabeth A Blair; Ezra E W Cohen; Daniel J Haraf; Marcy A List; Abhishek A Solanki; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Joseph K Salama
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Oral oncology 2012;48(10):1025-30.
2011: V M Villaflor; Everett E Vokes; R D Williams; Mary Ellyn Witt; P Beniwal; E A Blair; A J Dekker; G Gomez-Abuin; Daniel J Haraf; Masha Kocherginsky; Alexander Langerman; Louis Portugal; Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; Ezra E W Cohen
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(11):2501-7.
2011: Kevin S Choe; Ezra E W Cohen; Daniel J Haraf; Louis Portugal; Tanguy Y Seiwert; Abhishek Solanki; Kerstin M Stenson; Victoria M Villaflor; Everett E Vokes; Mary Ellyn Witt; Elizabeth A Blair; Joseph K Salama
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Cancer 2011;117(20):4671-8.
2011: Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; E A Blair; Ezra E W Cohen; Daniel J Haraf; R Kunnavakkam; R Williams; Mary Ellyn Witt; Everett E Vokes
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(10):2304-9.
2011: Aaron W Pederson; Joseph K Salama; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Elizabeth A Blair; Daniel J Haraf
Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
American journal of clinical oncology 2011;34(4):356-61.
2011: Michael A Nichols; Loren K Mell; Michael D Hasselle; Theodore G Karrison; Dhara MacDermed; Amber Meriwether; Mary Ellyn Witt; Ralph R Weichselbaum; Steven J Chmura
Outcomes in black patients with early breast cancer treated with breast conservation therapy.
International journal of radiation oncology, biology, physics 2011;79(2):392-9.
2011: Aaron W Pederson; Louis Portugal; Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; Victoria M Villaflor; Everett E Vokes; Mary Ellyn Witt; Ezra E W Cohen; Daniel J Haraf; Elizabeth A Blair
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Head & neck oncology 2011;3():31.
2010: Kent W Mouw; Daniel J Haraf; Kerstin M Stenson; Ezra E Cohen; Xi Xi; Mary Ellyn Witt; Marcy List; Elizabeth A Blair; Everett E Vokes; Joseph K Salama
Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.
Archives of otolaryngology--head & neck surgery 2010;136(12):1226-34.
2010: Kevin S Choe; Joseph K Salama; Kerstin M Stenson; Elizabeth A Blair; Mary Ellyn Witt; Ezra E W Cohen; Daniel J Haraf; Everett E Vokes
Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;97(2):318-21.
2010: Aaron W Pederson; Daniel J Haraf; Mary Ellyn Witt; Kerstin M Stenson; Everett E Vokes; Elizabeth A Blair; Joseph K Salama
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.
Head & neck 2010;32(11):1519-27.
2010: Ezra E W Cohen; Daniel J Haraf; Rangesh Kunnavakkam; Kerstin M Stenson; Elizabeth A Blair; Bruce E Brockstein; Eric P Lester; Joseph K Salama; Allison Dekker; Rosalyn Williams; Mary Ellyn Witt; Tatyana A Grushko; James J Dignam; Mark W Lingen; Olufunmilayo I Olopade; Everett E Vokes
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3336-43.
2010: Aaron W Pederson; Daniel J Haraf; Elizabeth A Blair; Kerstin M Stenson; Mary Ellyn Witt; Everett E Vokes; Joseph K Salama
Chemoreirradiation for recurrent salivary gland malignancies.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;95(3):308-11.
2010: Loren K Mell; James J Dignam; Joseph K Salama; Ezra E W Cohen; Blase N Polite; Virag Dandekar; Amit D Bhate; Mary Ellyn Witt; Daniel J Haraf; Bharat B Mittal; Everett E Vokes; Ralph R Weichselbaum
Predictors of competing mortality in advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):15-20.
2009: Ezra E W Cohen; Joshua Baru; Dezheng Huo; Daniel J Haraf; Maureen Crowley; Mary Ellyn Witt; Elizabeth A Blair; Ralph R Weichselbaum; Fred Rosen; Everett E Vokes; Kerstin M Stenson
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Head & neck 2009;31(8):1013-21.
2008: Joseph K Salama; Kerstin M Stenson; Emily O Kistner; Bharat B Mittal; Athanassios Argiris; Mary Ellyn Witt; Fred R Rosen; Bruce E Brockstein; Ezra E W Cohen; Daniel J Haraf; Everett E Vokes
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1787-94.
2008: B R Knab; Joseph K Salama; A Solanki; Kerstin M Stenson; Ezra E W Cohen; Mary Ellyn Witt; Daniel J Haraf; Everett E Vokes
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(9):1650-4.
2008: Tanguy Seiwert; Daniel J Haraf; Ezra E W Cohen; Kerstin M Stenson; Mary Ellyn Witt; Allison Dekker; Masha Kocherginsky; Ralph R Weichselbaum; Helen X Chen; Everett E Vokes
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1732-41.
2006: Ezra E W Cohen; Daniel J Haraf; Marcy A List; Masha Kocherginsky; Bharat B Mittal; Fred R Rosen; Bruce E Brockstein; Rosalyn Williams; Mary Ellyn Witt; Kerstin M Stenson; Merrill S Kies; Everett E Vokes
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3438-44.
2006: Michael T Milano; Everett E Vokes; Johnny Kao; Wells Jackson; Marcy A List; Kerstin M Stenson; Mary Ellyn Witt; Allison Dekker; Ellen MacCracken; Michael C Garofalo; Steven J Chmura; Ralph R Weichselbaum; Daniel J Haraf
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
International journal of oncology 2006;28(5):1141-51.
2006: Joseph K Salama; Everett E Vokes; Steven J Chmura; Michael T Milano; Johnny Kao; Kerstin M Stenson; Mary Ellyn Witt; Daniel J Haraf
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
International journal of radiation oncology, biology, physics 2006;64(2):382-91.
2005: Michael T Milano; Everett E Vokes; Joseph K Salama; Kerstin M Stenson; Johnny Kao; Mary Ellyn Witt; Bharat B Mittal; Athanassios Argiris; Ralph R Weichselbaum; Daniel J Haraf
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
International journal of radiation oncology, biology, physics 2005;61(4):1096-106.
2005: Joseph K Salama; Daniel J Haraf; Kerstin M Stenson; Michael T Milano; Mary Ellyn Witt; Everett E Vokes
Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
Cancer journal (Sudbury, Mass.) 2005;11(2):140-6.
2004: Michael T Milano; Daniel J Haraf; Kerstin M Stenson; Mary Ellyn Witt; Cathy Eng; Bharat B Mittal; Athanassios Argiris; Harold Pelzer; Mark F. Kozloff; Everett E Vokes
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):4922-32.
2004: Bruce E Brockstein; Daniel J Haraf; Alfred W Rademaker; Merrill S Kies; Kerstin M Stenson; Fred R Rosen; Bharat B Mittal; Harold Pelzer; B B Fung; Mary Ellyn Witt; Barry L Wenig; Louis Portugal; R W Weichselbaum; Everett E Vokes
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1179-86.
2003: Mary Ellyn Witt; Marilyn Haas; Marie A Marrinan; Carol N Brown
Understanding stereotactic radiosurgery for intracranial tumors, seed implants for prostate cancer, and intravascular brachytherapy for cardiac restenosis.
Cancer nursing 2003;26(6):494-502.
2003: Daniel J Haraf; Fred R Rosen; Kerstin M Stenson; Athanassios Argiris; Bharat B Mittal; Mary Ellyn Witt; Bruce E Brockstein; Marcy A List; Louis Portugal; Harold Pelzer; Ralph R Weichselbaum; Everett E Vokes
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5936-43.
2003: Fred R Rosen; Daniel J Haraf; Merrill S Kies; Kerstin M Stenson; Louis Portugal; Marcy A List; Bruce E Brockstein; Bharat B Mittal; Alfred W Rademaker; Mary Ellyn Witt; Harold Pelzer; Ralph R Weichselbaum; Everett E Vokes
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1689-97.
2003: J L Oh; Everett E Vokes; Merrill S Kies; Bharat B Mittal; Mary Ellyn Witt; Ralph R Weichselbaum; Daniel J Haraf
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):564-9.
2003: Everett E Vokes; Kerstin M Stenson; Fred R Rosen; Merrill S Kies; Alfred W Rademaker; Mary Ellyn Witt; Bruce E Brockstein; Marcy A List; Bing Bing Fung; Louis Portugal; Bharat B Mittal; Harold Pelzer; Ralph R Weichselbaum; Daniel J Haraf
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):320-6.
2001: CA Mantz; Everett E Vokes; Merrill S Kies; B Mittal; Mary Ellyn Witt; Marcy A List; Ralph R Weichselbaum; Daniel J Haraf
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):343-7.
2001: CA Mantz; Everett E Vokes; Kerstin M Stenson; Merrill S Kies; B Mittal; Mary Ellyn Witt; Marcy A List; Ralph R Weichselbaum; Daniel J Haraf
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Cancer journal (Sudbury, Mass.) 2001;7(2):140-8.
2000: Bruce E Brockstein; Daniel J Haraf; Kerstin M Stenson; L Sulzen; Mary Ellyn Witt; R W Weichselbaum; Everett E Vokes
A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):721-8.
2000: Everett E Vokes; Merrill S Kies; Daniel J Haraf; Kerstin M Stenson; Marcy A List; Rod A Humerickhouse; M Eileen Dolan; Harold Pelzer; L Sulzen; Mary Ellyn Witt; Y C Hsieh; Bharat B Mittal; Ralph R Weichselbaum
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1652-61.
1999: M M Lee; Everett E Vokes; A Rosen; Mary Ellyn Witt; Ralph R Weichselbaum; Daniel J Haraf
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
The cancer journal from Scientific American 1999;5(4):219-23.
1999: Daniel J Haraf; Merrill S Kies; Alfred W Rademaker; Kerstin M Stenson; B Mittal; Harold Pelzer; Barry L Wenig; Mary Ellyn Witt; L Sulzen; Ralph R Weichselbaum; Everett E Vokes
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):638-44.
1998: Mary Ellyn Witt
Radiation and chemotherapy as combined treatment for advanced head and neck cancer.
Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 1998;7(3):159-64.
1997: Daniel J Haraf; Kerstin M Stenson; Marcy A List; Mary Ellyn Witt; Ralph R Weichselbaum; Everett E Vokes
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
Seminars in oncology 1997;24(1 Suppl 2):S2-68-S2-71.